|
Transplantation
Citations 231-240 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
- Stephanie J. Lee, John Klein, Michael Haagenson, Lee Ann Baxter-Lowe, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Neal Flomenberg, Mary Horowitz, Carolyn K. Hurley, Harriet Noreen, Machteld Oudshoorn, Effie Petersdorf, Michelle Setterholm, Stephen Spellman, Daniel Weisdorf, Thomas M. Williams, and Claudio Anasetti
Blood 2007; 110: 4576-4583.
[Abstract]
[Full text]
[PDF]
A prospective study of G-CSF–primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study
- Haydar Frangoul, Eneida R. Nemecek, Dean Billheimer, Michael A. Pulsipher, Shakila Khan, Ann Woolfrey, Becky Manes, Catherine Cole, Mark C. Walters, Mouhab Ayas, Yaddanapudi Ravindranath, John E. Levine, and Stephan A. Grupp
Blood 2007; 110: 4584-4587.
[Abstract]
[Full text]
[PDF]
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
- Robert Zeiser, Sawsan Youssef, Jeanette Baker, Neeraja Kambham, Lawrence Steinman, and Robert S. Negrin
Blood 2007; 110: 4588-4598.
[Abstract]
[Full text]
[PDF]
Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients
- Lindsay M. Morton, Ola Landgren, Nilanjan Chatterjee, David Castenson, Ruth Parsons, Robert N. Hoover, and Eric A. Engels
Blood 2007; 110: 4599-4605.
[Abstract]
[Full text]
[PDF]
Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
- Mohamed L. Sorror, Sergio Giralt, Brenda M. Sandmaier, Marcos De Lima, Munir Shahjahan, David G. Maloney, H. Joachim Deeg, Frederick R. Appelbaum, Barry Storer, and Rainer Storb
Blood 2007; 110: 4606-4613.
[Abstract]
[Full text]
[PDF]
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia
- Eduardo Olavarria, Shamyla Siddique, Michael J. Griffiths, Sharon Avery, Jenny L. Byrne, Karen P. Piper, Anne L. Lennard, Lalit Pallan, Julie M. Arrazi, Jolanta B. Perz, Derville O'Shea, John M. Goldman, Jane F. Apperley, and Charles F. Craddock
Blood 2007; 110: 4614-4617.
[Abstract]
[Full text]
[PDF]
No more transplantation in CML?
- Timothy Littlewood, Ram Malladi, and Andrew Peniket
Blood 2007; 110: 4618.
[Full text]
[PDF]
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation
- Karen P. Piper, Claire Horlock, S. John Curnow, Julie Arrazi, Sarah Nicholls, Premini Mahendra, Charles Craddock, and Paul A. H. Moss
Blood 2007; 110: 3827-3832.
[Abstract]
[Full text]
[PDF]
Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft
- Marina Deschamps, Patricia Mercier-Lethondal, Jean Marie Certoux, Carole Henry, Bruno Lioure, Céline Pagneux, Jean Yves Cahn, Eric Deconinck, Eric Robinet, Pierre Tiberghien, and Christophe Ferrand
Blood 2007; 110: 3842-3852.
[Abstract]
[Full text]
[PDF]
Rapidly induced, T-cell–independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells
- Shengqiao Li, Yehong Yan, Yuan Lin, Dominique M. Bullens, Omer Rutgeerts, Jozef Goebels, Constant Segers, Louis Boon, Ahmad Kasran, Rita De Vos, Christiane Dewolf-Peeters, Mark Waer, and An D. Billiau
Blood 2007; 110: 3926-3935.
[Abstract]
[Full text]
[PDF]
|
|
